Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
Main Author: | |
---|---|
Publication Date: | 2018 |
Other Authors: | , , |
Format: | Article |
Language: | eng |
Source: | International Archives of Otorhinolaryngology |
Download full: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300245 |
Summary: | Abstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many differentmodalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatmentmodalities of ISSNHL and to compare the results if HOTwas not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL. |
id |
FORL-1_645148a7ff742ef9acec7b5d446baa80 |
---|---|
oai_identifier_str |
oai:scielo:S1809-48642018000300245 |
network_acronym_str |
FORL-1 |
network_name_str |
International Archives of Otorhinolaryngology |
repository_id_str |
|
spelling |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalitieshearing losshyperbaric oxygen therapysteroidsintratympanic injectionAbstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many differentmodalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatmentmodalities of ISSNHL and to compare the results if HOTwas not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL.Fundação Otorrinolaringologia2018-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300245International Archives of Otorhinolaryngology v.22 n.3 2018reponame:International Archives of Otorhinolaryngologyinstname:Fundação Otorrinolaringologia (FORL)instacron:FORL10.1055/s-0037-1605376info:eu-repo/semantics/openAccessKhater,AhmedEl-Anwar,Mohammad WaheedNofal,Ahmad Abdel-FattahElbahrawy,Atef Tahaeng2018-10-08T00:00:00Zoai:scielo:S1809-48642018000300245Revistahttps://www.scielo.br/j/iao/https://old.scielo.br/oai/scielo-oai.php||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br1809-48641809-4864opendoar:2018-10-08T00:00International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)false |
dc.title.none.fl_str_mv |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
title |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
spellingShingle |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities Khater,Ahmed hearing loss hyperbaric oxygen therapy steroids intratympanic injection |
title_short |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
title_full |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
title_fullStr |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
title_full_unstemmed |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
title_sort |
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities |
author |
Khater,Ahmed |
author_facet |
Khater,Ahmed El-Anwar,Mohammad Waheed Nofal,Ahmad Abdel-Fattah Elbahrawy,Atef Taha |
author_role |
author |
author2 |
El-Anwar,Mohammad Waheed Nofal,Ahmad Abdel-Fattah Elbahrawy,Atef Taha |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Khater,Ahmed El-Anwar,Mohammad Waheed Nofal,Ahmad Abdel-Fattah Elbahrawy,Atef Taha |
dc.subject.por.fl_str_mv |
hearing loss hyperbaric oxygen therapy steroids intratympanic injection |
topic |
hearing loss hyperbaric oxygen therapy steroids intratympanic injection |
description |
Abstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many differentmodalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatmentmodalities of ISSNHL and to compare the results if HOTwas not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-07-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300245 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300245 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1055/s-0037-1605376 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
dc.source.none.fl_str_mv |
International Archives of Otorhinolaryngology v.22 n.3 2018 reponame:International Archives of Otorhinolaryngology instname:Fundação Otorrinolaringologia (FORL) instacron:FORL |
instname_str |
Fundação Otorrinolaringologia (FORL) |
instacron_str |
FORL |
institution |
FORL |
reponame_str |
International Archives of Otorhinolaryngology |
collection |
International Archives of Otorhinolaryngology |
repository.name.fl_str_mv |
International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL) |
repository.mail.fl_str_mv |
||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br |
_version_ |
1754203976104935424 |